Presentation is loading. Please wait.

Presentation is loading. Please wait.

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility 

Published bySofie Vedder Modified over 6 years ago

Similar presentations

Presentation on theme: "Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility "— Presentation transcript:

1 Development of in vitro maturation techniques for clinical applications 
Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility  Volume 108, Issue 4, Pages (October 2017) DOI: /j.fertnstert Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Protocol for mild-stimulation cycle in vitro fertilization (IVF) combined with in vitro maturation (IVM) treatment. ET = embryo transfer; ICSI = intracytoplasmic sperm injection; MII = metaphase II; OPU = oocyte pick-up. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2017 American Society for Reproductive Medicine Terms and Conditions

Download ppt "Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D.  Fertility and Sterility "

Similar presentations

Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.

Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human.
Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 

Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.
Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,

Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome  Michel De Vos,
Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 

Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication  Thamara Viloria,
Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada  Natalie Dayan, M.D., Andrea Lanes, M.Sc.,

Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada  Natalie Dayan, M.D., Andrea Lanes, M.Sc.,
Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis.

Developmental capacity of in vitro–matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm  Luis.
Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W

Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 

Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.
Effect of a very-low-calorie diet on in vitro fertilization outcomes

Effect of a very-low-calorie diet on in vitro fertilization outcomes
Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time  Patricia Fauque, M.D.,

Successful delivery after the transfer of embryos obtained from a cohort of incompletely in vivo matured oocytes at retrieval time  Patricia Fauque, M.D.,
Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community 

Outcomes from a university-based low-cost in vitro fertilization program providing access to care for a low-resource socioculturally diverse urban community 
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study  Leonidas Mamas, M.D., Ph.D. 
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Live birth of twins derived from zona-free oocytes

Live birth of twins derived from zona-free oocytes

Similar presentations

Ads by Google